Rome, Italy

Danelli Tamara

This inventor holds 1 USPTO granted patent. Top assignees: Instituto Nazionale Per Lo Studio E La Cura Dei Tumori, Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2007.


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Danelli Tamara: Innovator in Pharmaceutical Chemistry

Introduction

Danelli Tamara is a notable inventor based in Rome, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as topoisomerase I inhibitors. Her work has implications for cancer treatment, showcasing her dedication to advancing medical science.

Latest Patents

Tamara holds a patent for "Camptothecins with a modified lactone ring." This patent describes compounds of formula (I) or (II), where the groups are defined in the detailed description. The patent includes racemic mixtures, individual enantiomers, individual diastereoisomers, their mixtures, and pharmaceutically acceptable salts. These compounds are recognized for their potential as effective topoisomerase I inhibitors, which are crucial in cancer therapy.

Career Highlights

Throughout her career, Danelli Tamara has worked with esteemed organizations such as the National Cancer Institute (Instituto Nazionale Per Lo Studio E La Cura Dei Tumori) and Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Tamara has collaborated with notable colleagues, including Maria Ornella Tinti and Marco Alpegiani. These partnerships have enriched her research and expanded the impact of her innovations in pharmaceutical chemistry.

Conclusion

Danelli Tamara's contributions to the field of pharmaceutical chemistry, particularly through her patent on camptothecins, highlight her role as an innovator in cancer treatment. Her collaborations and career achievements reflect her commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…